Equivalence and Noninferiority Testing in Regression Models and Repeated-Measures Designs

被引:80
作者
Mascha, Edward J. [1 ,2 ]
Sessler, Daniel I. [2 ]
机构
[1] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44195 USA
关键词
NON-INFERIORITY TRIALS; LONGITUDINAL DATA-ANALYSIS; CLINICAL-TRIALS; COMPARATIVE EFFICACY; NULL HYPOTHESIS; STATISTICS; LEAST; DIFFERENCE; CRITERION; OUTCOMES;
D O I
10.1213/ANE.0b013e318206f872
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Equivalence and noninferiority designs are useful when the superiority of one intervention over another is neither expected nor required. Equivalence trials test whether a difference between groups falls within a prespecified equivalence region, whereas noninferiority trials test whether a preferred intervention is either better or at least not worse than the comparator, with worse being defined a priori. Special designs and analyses are needed because neither of these conclusions can be reached from a nonsignificant test for superiority. Using the data from a companion article, we demonstrate analyses of basic equivalence and noninferiority designs, along with more complex model-based methods. We first give an overview of methods for design and analysis of data from superiority, equivalence, and noninferiority trials, including how to analyze each type of design using linear regression models. We then show how the analogous hypotheses can be tested in a repeated-measures setting in which there are multiple outcomes per subject. We especially address interactions between the repeated factor, usually time, and treatment. Although we focus on the analysis of continuous outcomes, extensions to other data types as well as sample size consideration are discussed. (Anesth Analg 2011;112:678-87)
引用
收藏
页码:678 / 687
页数:10
相关论文
共 40 条
[1]   STATISTICS NOTES - ABSENCE OF EVIDENCE IS NOT EVIDENCE OF ABSENCE [J].
ALTMAN, DG ;
BLAND, JM .
BRITISH MEDICAL JOURNAL, 1995, 311 (7003) :485-485
[2]  
[Anonymous], 2003, Testing statistical hypotheses of equivalence
[3]   PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].
BLACKWELDER, WC .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353
[4]   Equivalence testing with dental clinical trials [J].
Burns, DR ;
Elswick, RK .
JOURNAL OF DENTAL RESEARCH, 2001, 80 (06) :1513-1517
[5]  
Chow S. C., 1992, Design and Analysis of Bioavailability and Bioequivalence Studies
[6]   Methodology of superiority vs. equivalence trials and non-inferiority trials [J].
Christensen, Erik .
JOURNAL OF HEPATOLOGY, 2007, 46 (05) :947-954
[7]   HOW TO ESTABLISH EQUIVALENCE WHEN DATA ARE CENSORED - A RANDOMIZED TRIAL OF TREATMENTS FOR B-NON-HODGKIN LYMPHOMA [J].
COMNOUGUE, C ;
RODARY, C ;
PATTE, C .
STATISTICS IN MEDICINE, 1993, 12 (14) :1353-1364
[8]   Methods for Equivalence and Noninferiority Testing [J].
da Silva, Gisela Tunes ;
Logan, Brent R. ;
Klein, John P. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) :120-127
[9]  
Dahmen G, 2004, METHOD INFORM MED, V43, P451
[10]  
Ebbutt AF, 1998, STAT MED, V17, P1691, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1691::AID-SIM971>3.0.CO